Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

Abstract Frontotemporal dementia (FTD) is a neurodegenerative disorder predominantly affecting the frontal and temporal lobes. Genome-wide association studies (GWAS) on FTD identified only a few risk loci. One of the possible explanations is that FTD is clinically, pathologically, and genetically he...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E. Taskesen, A. Mishra, S. van der Sluis, R. Ferrari, International FTD-Genomics Consortium, J. H. Veldink, M. A. van Es, A. B. Smit, D. Posthuma, Y. Pijnenburg
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c79399bebb3a41f0b010828d72d25a15
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c79399bebb3a41f0b010828d72d25a15
record_format dspace
spelling oai:doaj.org-article:c79399bebb3a41f0b010828d72d25a152021-12-02T12:32:54ZSusceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS10.1038/s41598-017-09320-z2045-2322https://doaj.org/article/c79399bebb3a41f0b010828d72d25a152017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-09320-zhttps://doaj.org/toc/2045-2322Abstract Frontotemporal dementia (FTD) is a neurodegenerative disorder predominantly affecting the frontal and temporal lobes. Genome-wide association studies (GWAS) on FTD identified only a few risk loci. One of the possible explanations is that FTD is clinically, pathologically, and genetically heterogeneous. An important open question is to what extent epigenetic factors contribute to FTD and whether these factors vary between FTD clinical subgroup. We compared the DNA-methylation levels of FTD cases (n = 128), and of FTD cases with Amyotrophic Lateral Sclerosis (FTD-ALS; n = 7) to those of unaffected controls (n = 193), which resulted in 14 and 224 candidate genes, respectively. Cluster analysis revealed significant class separation of FTD-ALS from controls. We could further specify genes with increased susceptibility for abnormal gene-transcript behavior by jointly analyzing DNA-methylation levels with the presence of mutations in a GWAS FTD-cohort. For FTD-ALS, this resulted in 9 potential candidate genes, whereas for FTD we detected 1 candidate gene (ELP2). Independent validation-sets confirmed the genes DLG1, METTL7A, KIAA1147, IGHMBP2, PCNX, UBTD2, WDR35, and ELP2/SLC39A6 among others. We could furthermore demonstrate that genes harboring mutations and/or displaying differential DNA-methylation, are involved in common pathways, and may therefore be critical for neurodegeneration in both FTD and FTD-ALS.E. TaskesenA. MishraS. van der SluisR. FerrariInternational FTD-Genomics ConsortiumJ. H. VeldinkM. A. van EsA. B. SmitD. PosthumaY. PijnenburgNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-16 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
E. Taskesen
A. Mishra
S. van der Sluis
R. Ferrari
International FTD-Genomics Consortium
J. H. Veldink
M. A. van Es
A. B. Smit
D. Posthuma
Y. Pijnenburg
Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS
description Abstract Frontotemporal dementia (FTD) is a neurodegenerative disorder predominantly affecting the frontal and temporal lobes. Genome-wide association studies (GWAS) on FTD identified only a few risk loci. One of the possible explanations is that FTD is clinically, pathologically, and genetically heterogeneous. An important open question is to what extent epigenetic factors contribute to FTD and whether these factors vary between FTD clinical subgroup. We compared the DNA-methylation levels of FTD cases (n = 128), and of FTD cases with Amyotrophic Lateral Sclerosis (FTD-ALS; n = 7) to those of unaffected controls (n = 193), which resulted in 14 and 224 candidate genes, respectively. Cluster analysis revealed significant class separation of FTD-ALS from controls. We could further specify genes with increased susceptibility for abnormal gene-transcript behavior by jointly analyzing DNA-methylation levels with the presence of mutations in a GWAS FTD-cohort. For FTD-ALS, this resulted in 9 potential candidate genes, whereas for FTD we detected 1 candidate gene (ELP2). Independent validation-sets confirmed the genes DLG1, METTL7A, KIAA1147, IGHMBP2, PCNX, UBTD2, WDR35, and ELP2/SLC39A6 among others. We could furthermore demonstrate that genes harboring mutations and/or displaying differential DNA-methylation, are involved in common pathways, and may therefore be critical for neurodegeneration in both FTD and FTD-ALS.
format article
author E. Taskesen
A. Mishra
S. van der Sluis
R. Ferrari
International FTD-Genomics Consortium
J. H. Veldink
M. A. van Es
A. B. Smit
D. Posthuma
Y. Pijnenburg
author_facet E. Taskesen
A. Mishra
S. van der Sluis
R. Ferrari
International FTD-Genomics Consortium
J. H. Veldink
M. A. van Es
A. B. Smit
D. Posthuma
Y. Pijnenburg
author_sort E. Taskesen
title Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS
title_short Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS
title_full Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS
title_fullStr Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS
title_full_unstemmed Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS
title_sort susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with amyotrophic lateral sclerosis by dna-methylation and gwas
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/c79399bebb3a41f0b010828d72d25a15
work_keys_str_mv AT etaskesen susceptiblegenesanddiseasemechanismsidentifiedinfrontotemporaldementiaandfrontotemporaldementiawithamyotrophiclateralsclerosisbydnamethylationandgwas
AT amishra susceptiblegenesanddiseasemechanismsidentifiedinfrontotemporaldementiaandfrontotemporaldementiawithamyotrophiclateralsclerosisbydnamethylationandgwas
AT svandersluis susceptiblegenesanddiseasemechanismsidentifiedinfrontotemporaldementiaandfrontotemporaldementiawithamyotrophiclateralsclerosisbydnamethylationandgwas
AT rferrari susceptiblegenesanddiseasemechanismsidentifiedinfrontotemporaldementiaandfrontotemporaldementiawithamyotrophiclateralsclerosisbydnamethylationandgwas
AT internationalftdgenomicsconsortium susceptiblegenesanddiseasemechanismsidentifiedinfrontotemporaldementiaandfrontotemporaldementiawithamyotrophiclateralsclerosisbydnamethylationandgwas
AT jhveldink susceptiblegenesanddiseasemechanismsidentifiedinfrontotemporaldementiaandfrontotemporaldementiawithamyotrophiclateralsclerosisbydnamethylationandgwas
AT mavanes susceptiblegenesanddiseasemechanismsidentifiedinfrontotemporaldementiaandfrontotemporaldementiawithamyotrophiclateralsclerosisbydnamethylationandgwas
AT absmit susceptiblegenesanddiseasemechanismsidentifiedinfrontotemporaldementiaandfrontotemporaldementiawithamyotrophiclateralsclerosisbydnamethylationandgwas
AT dposthuma susceptiblegenesanddiseasemechanismsidentifiedinfrontotemporaldementiaandfrontotemporaldementiawithamyotrophiclateralsclerosisbydnamethylationandgwas
AT ypijnenburg susceptiblegenesanddiseasemechanismsidentifiedinfrontotemporaldementiaandfrontotemporaldementiawithamyotrophiclateralsclerosisbydnamethylationandgwas
_version_ 1718393945634897920